Prevalencia de hipotiroidismo subclínico, deterioro cognitivo y su posible asociación en adultos mayores de una clínica de la Ciudad de México 2016
PDF (Español (España))
HTML (Español (España))
XML (Español (España))

Keywords

Hypothyroidism
Cognitive dysfunction
Aged
Quality of life
Mental health

How to Cite

Esquivel Salgado, M. M., Olivares Luna, A. M., & Pedraza Avilés, A. G. (2018). Prevalencia de hipotiroidismo subclínico, deterioro cognitivo y su posible asociación en adultos mayores de una clínica de la Ciudad de México 2016. Médicas UIS, 31(3), 21–25. https://doi.org/10.18273/revmed.v31n3-2018002

Abstract

Introduction: hypothyroidism has been related to cognitive impairment, as well as a reduction in life quality, however, controversy exists in this matter because evidence is contradictory. Hypothyroidism seems to cause changes in elderly´s cognitive and emotional state. Studies are required to establish such relationship, and to evaluate substitute hormonal treatment. Objective: to determine the prevalence of subclinical hypothyroidism and cognitive impairment in older adults and its possible association in elderly patients. Material and Methods: cross-sectional, analytic, descriptive study, carried out in a Gerontology Module from Family Medicine Clinic “Dr. Ignacio Chávez” in Mexico City, from june to november 2016. Non probabilistic convenience sampling was done. Mini Mental Status Exam was applied for cognitive impairment. Blood Samples were sent to laboratory to make thyroid function tests. Statistical Analysis including independence Chi-Square with significance level 0,05. Statistical Package for the Social Science version 22 was used. Results: 120 older adults were studied, the average age was 78,2. 35.8% of the patients presented subclinical hypothyroidism, and 63% presented some degree of cognitive impairment. While relating this variables, no statistical significance was obtained (p=0,556). Conclusions: The present study demonstrated a high prevalence of subclinical hypothyroidism and cognitive impairment in the study population. The relationship between the two variables was not demonstrated. MÉD.UIS. 2018;31(3):21-25.

https://doi.org/10.18273/revmed.v31n3-2018002
PDF (Español (España))
HTML (Español (España))
XML (Español (España))

References

1. Custodio N, Lira D, Montesinos R, Bendezú L, Cortijo P. Diagnóstico y tratamiento de la enfermedad de alzheimer en países en vías de desarrollo: aproximación a nuestra realidad.
Interciencia. 2010;1(1):11-21.
2. Ceresini G, Lauretani F, Maggio M, Ceda GP, Morganti S, Usberti E, et al. Thyroid function abnormalities and cognitive impairment in elderly people: results of the in Chianti study. J Am Geriatr Soc. 2009;57(1):89–93.
3. Guía de Práctica Clínica. Diagnóstico y tratamiento del
hipotiroidismo primario y subclínico en el adulto. Actualización
2016. [Internet]. Cenetec.salud.gob.mx. 2017 [Citado 17 Octubre
2016]. Disponible en: http://www.cenetec.salud.gob.mx/
descargas/gpc/CatalogoMaestro/265_IMSS_10_Hipotiroidismo_
Primario/GRR_IMSS_262_10.pdf
4. Gómez-Meléndez GA, Ruiz-Betanzos R, Sánchez-Pedraza V,
Segovia-Palomo A, Mendoza-Hernández CF, Arellano-Montaño
S. Hipotiroidismo. Med Int Mex. 2010;26(5):462-471.
5. Doucet J, Trivalle C, Chassagna P, Perol MB, Vuillermet P,
Manchon ND, et al. Does age play a role in clinical presentation
of hypothyroidism? J. Am. Geriat Soc. 1994;42(9)984-6.
6. García BC. Enfermedades endocrinas en el adulto mayor. Rev
Med Clin Condes. 2013;24(5):866-873.
7. Vaidya B, Pearce SHS. Management of hypothyroidism in adults.
BMJ. 2008;337:a801.
8. Gonzales-Gonzales C, Deza F, León F, Poma J. Hipotiroidismo
subclínico, depresión y deterioro cognitivo: experiencia en
un centro de adultos mayores de Lambayeque. An Fac Med.
2014;75(4):327-30.
9. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh
JP, et al. Subclinical hypothyroidism and the risk of coronary
heart disease and mortality. JAMA. 2010;304(12):1365-74.
10. Gencer B, Collet T, Virgini V, Bauer D, Gussekloo J, Cappola
A, et al. Thyroid Studies Collaboration. Subclinical thyroid
dysfunction and the risk of heart failure events: an individual
participant data analysis from 6 prospective cohorts. Circulation.
2012;126(9):1040-9.
11. Joshi S, Morley JE. Cognitive Impairment. Med Clin North Am.
2006;90(5):769-87.
12. ENASEM. Estudio Nacional de Salud y Envejecimiento en
México. Archivos de Datos y Documentación (uso público).
(Citado 15 Octubre 2018). Disponible en: http://www.enasem.org
13. Sánchez-Rodríguez JL, Torrellas-Morales C. Revisión del
constructo deterioro cognitivo leve: aspectos generales. Rev
Neurol. 2011;52(5):300-5.
14. Robles A, Del Ser T, Alom J, Peña-Casanova J. Grupo Asesor
del Grupo de Neurología de la Conducta y Demencias de la
Sociedad Española de Neurología. Propuesta de criterios para el
diagnóstico clínico del deterioro cognitivo ligero, la demencia y
la enfermedad de Alzheimer. Rev Neurol. 2002;17(1):17-32.
15. Parsaik AK, Singh B, Roberts RO, Pankratz Sh, Edwards KK, Geda
YE, et al. Hypothyroidism and risk of mild cognitive impairment
in elderly persons: a population-based study. JAMA Neurol.
2014;71(2):201-7.
16. Nguyen HT, Black SA, Ray LA, Espino DV, Markides KS.
Predictors of decline in MMSE scores among older Mexican
Americans. J Gerontol A Biol Sci Med Sci. 2002;57(3):M181-185.
17. Samuels MH. Psychiatric and cognitive manifestations
of hypothyroidism. Curr Opin Endocrinol Diabetes Obes.
2014;21(5):377-83.
18. Akintola AA, Jansen SW, van Bodegom D, van der Grond J,
Westendorp RG, de Craen AJ, et al. Subclinical hypothyroidism
and cognitive function in people over 60 years: a systematic
review and meta-analysis. Front Aging Neurosci. Aug 2015;
7:150.
19. Juárez-Cedillo T, Basurto-Acevedo L, Vega-García S, Sánchez-
Rodríguez M, Retana-Ugalde R, Juárez-Cedillo E, et al.
Prevalence of thyroid dysfunction and its impact on cognition in
older mexican adults: (SADEM study). J Endocrinol Invest. 2017;
40(9): 945-952.
20. Aubert CE, Bauer DC, da Costa BR, Feller M, Rieben C,
Simonsick EM, et al. The association between subclinical
thyroid dysfunction and dementia: The Health, Aging and Body
Composition (Health ABC) Study. Clin Endocrinol (Oxf). 2017;
87(5): 617-626.
21. Pedraza OL, Perilla HJ, Cruz A, Botero JA, Montalvo MC, Salazar
AM, et al. Deterioro cognitivo y factores de riesgo cardiovascular
y metabólico en una muestra de adultos de Bogotá. Acta Neurol
Colomb. 2016; 32(2): 91-99.
22. Wijsman LW, de Craen AJ, Trompet S, Gussekloo J, Stott DJ,
Rodondi N, et al. Subclinical thyroid dysfunction and cognitive
decline in old age. Plos One. 2013; 8(3):e59199.
23. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich
M, Westendorp RG. Thyroid status, disability and cognitive
function, and survival in old age. JAMA. 2004: 292(21): 2591–99.
24. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen
TG. Neuropsychological function and symptoms in subjects
with subclinical hypothyroidism and the effect of thyroxine
treatment. J Clin Endocrinol Metab. 2006; 91(1): 145–153.
25. Parle J, Roberts L, Wilson S, Pattison H, Roalfe A, Haque MS, et al. A
randomized controlled trial of the effect of thyroxine replacement
on cognitive function in community-living elderly subjects with
subclinical hypothyroidism: the Birmingham elderly thyroid
study. J Clin Endocrinol. Metab. 2010; 95(8):3623–32.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2018 Revista Médicas UIS

Downloads

Download data is not yet available.